Attenuated total reflection IR spectroscopy as a tool to investigate the orientation and tertiary structure changes in fusion proteins  by Martin, I et al.
www.bba-direct.com
Biochimica et Biophysica Acta 1614 (2003) 97–103Review
Attenuated total reflection IR spectroscopy as a tool to investigate the
orientation and tertiary structure changes in fusion proteins
I. Martin, E. Goormaghtigh, J.-M. Ruysschaert*
Structure and Function of Biological Membranes, Center of Structural Biology and Bioinformatics, Universite´ Libre de Bruxelles,
Boulevard du Triomphe C.P. 206/2, B-1050 Brussels, BelgiumReceived 28 April 2003; accepted 15 May 2003Abstract
Membrane fusion proceeds via a merging of two lipid bilayers and a redistribution of aqueous contents and bilayer components. It
involves transition states in which the phospholipids are not arranged in bilayers and in which the monolayers are highly curved. Such
transition states are energetically unfavourable since biological membranes are submitted to strong repulsive hydration electrostatic and steric
barriers. Viral membrane proteins can help to overcome these barriers. Viral proteins involved in membrane fusion are membrane associated
and the presence of lipids restricts drastically the potential of methods (RMN, X-ray crystallography) that have been used successfully to
determine the tertiary structure of soluble proteins. We describe here how IR spectroscopy allows to solve some of the problems related to the
lipid environment.
The principles of the method, the experimental setup and the preparation of the samples are briefly described. A few examples illustrate
how attenuated total reflection Fourier-transform IR (ATR-FTIR) spectroscopy can be used to gain information on the orientation and the
accessibility to the water phase of the fusogenic domain of viral proteins. Recent developments suggest that the method could also be used to
detect changes located in the membrane domains and to identify intermediate structural states involved in the fusion process.D 2003 Elsevier B.V. All rights reserved.Keywords: Attenuated total reflection; IR spectroscopy; Fusion peptide orientation; Hydrogen/deuterium exchange; Dichroic spectra
1. Introduction induce local perturbations in the lipid bilayer through theirThe mechanism of membrane fusion involved in biolog-
ical processes such as endo- or exocytosis, membrane
recycling, fertilisation and enveloped virus infection is still
unclear. The question arises whether these fusion reactions
share features with each other. The best-characterised mech-
anisms of biological fusion are those used by enveloped
virus, such as influenza virus, to enter their host cells.
Membrane fusion proceeds via a merging of two lipid
bilayers and a redistribution of aqueous contents and bilayer
components. It involves transition states in which the phos-
pholipids are not arranged in bilayers and in which the
monolayers are highly curved [1–3]. Such transition states
are energetically unfavourable since biological membranes
are submitted to strong repulsive hydration electrostatic and
steric barriers. These barriers can be overcome by membrane
proteins. They facilitate local dehydration and are thought to0005-2736/03/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
doi:10.1016/S0005-2736(03)00167-6
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E-mail address: jmruyss@ulb.ac.be (J.-M. Ruysschaert).insertion into membranes. Among the few well-characterised
fusion proteins are viral spike glycoproteins responsible for
penetration of enveloped virus into their host cells [4] and
more particularly the hemagglutinin of influenza virus. In
spite of similar functions, viral fusion proteins are diverse
with little sequence similarities between various viruses [5–
7]. In their sequences, these proteins posses a ‘‘fusion
peptide’’, a short segment of relatively hydrophobic residue,
commonly found in a membrane-anchored polypeptide chain
[8]. Fusion peptide have also been identified in proteins
involved in gamete fusion [9], in myoblast fusion [10], in
vesicular fusion in neurons. Such peptides are implicated in
the fusion process. In general, the exposed fusion peptides
are believed to insert into the target cell membrane, and thus
cause the local destabilisation of the lipid bilayer necessary
to catalyse fusion. To simulate protein-mediated fusion,
many studies on peptide-induced membrane fusion have
been conducted on model membranes such as liposomes
and have employed synthetic peptides corresponding to the
putative fusion sequences of viral proteins [11–13].
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these proteins induce fusion requires a deeper knowledge of
the viral protein structure and of the structural states
involved in the fusion process. Most of the methods that
have been used successfully to determine the tertiary struc-
ture of soluble proteins cannot be used in a lipid environ-
ment and since most viral proteins are membrane proteins, a
knowledge of their tertiary structure remains a major chal-
lenge, and explains that in most cases only the tertiary
structure of ectodomains has been investigated as illustrated
for ectodomain of the influenza HA protein for which
atomic resolution is available for both its neutral and its
low pH form [14,15].
X-ray crystallography provides accurate structural data,
but obtaining high-quality crystals of membrane proteins is
still extremely difficult. Reasonably high resolution struc-
tures have been obtained for only a few unrelated membrane
proteins: [16–32]. The method is inherently static and the
three-dimensional crystals necessary to obtain atomic reso-
lution require the replacement of the lipid bilayer by
detergents. NMR spectroscopy remains limited to small
soluble proteins because the line-broadening effect associ-
ated with larger structures and nonisotropic motion of
proteins within the lipid matrix. Large membrane vesicles
containing both lipids and proteins or peptides are therefore
still difficult to examine. CD suffers from light scattering
and is prone to errors when large membrane fragments or
lipid vesicles have to be studied. Under such conditions, a
major effort is needed to correct the CD spectrum for
flattening effects. Fluorescence spectroscopy often requires
the use of perturbating probes and is also sensitive to light
scattering effects. Application of Raman spectroscopy to the
study of membrane proteins is promising, but is still limited
by the low signal-to-noise ratio usually caused by interfer-
ing luminescence background with a strong contribution
from chromophores. Raman spectroscopy does offer, how-
ever, a wealth of information on some amino acid side
chains, which is complementary to the infrared data.
IR spectroscopy remains extremely useful as a tool to
assess the structure of proteins that cannot be studied by X-
ray crystallography and NMR. Attenuated total reflection
Fourier-transform infrared spectroscopy (ATR-FTIR) is one
of the most powerful methods for recording IR spectra of
biological materials in general, and for biological mem-
branes in particular. It is fast, yields a strong signal with
only a few micrograms of sample, and most importantly
provides information about the secondary structure, the
orientation and the tertiary structure changes of a protein
in an oriented system. The environment of the molecules
can be modulated so that their conformation can be studied
as a function of temperature, pressure and pH, as well as in
the presence of specific ligands. Because of the long IR
wavelength, light scattering problems are virtually nonexis-
tent, and highly aggregated materials or large membrane
fragments can be investigated. A unique advantage of IR
spectroscopy is that it allows simultaneous study of thestructure of lipids and proteins in intact biological mem-
branes without introduction of foreign perturbing probes.
We describe here the principles of the method, the
experimental setup and the preparation of the samples. A
few examples illustrate how ATR-FTIR can be used to gain
information on the orientation and the accessibility to the
water-phase of the fusogenic domain of viral proteins.
Recent developments suggest that the method could also
be used to detect changes located in the membrane domains
and to identify intermediate structural states involved in the
fusion process.2. Polarised ATR-FTIR
2.1. Experimental setup
Various experimental setups have been designed, includ-
ing the use of optical fibres for the study of proteins [33–
36]. However, the most usual design is the germanium
trapezoidal plate, which allows molecular orientation to be
determined by means of linear dichroism for oriented
membranes. The IR beam is directed into a high refractive
index medium that is transparent for the IR radiation of
interest. Above a critical angle, which depends on the
refractive index of the plate and of the external medium,
the light beam is completely reflected when it impinges on
the surface of the plate. Several internal reflections occur
within the plate until the beam reaches the end. A detailed
description of the setup is available in Ref. [37]. Samples
that are deposited on the germanium plate absorb electro-
magnetic radiation of the evanescent wave and thereby
reduce the intensity of the reflected light. Hence, the
technique is referred to as ‘‘attenuated total reflection Four-
ier-transform IR spectroscopy’’.
2.2. Sample preparation
The sample preparation for ATR-FTIR spectroscopy
consists in spreading a drop of the sample, typically 5–50
Al containing 1–200 Ag of either a membrane suspension or
a protein solution on the germanium plate. The solvent is
slowly evaporated under a gentle N2 flow while a Teflon bar
or pipette tip is used to spread the liquid over the useful
surface in order to make the film as uniform as possible.
While evaporating, capillary forces flatten the membranes,
which spontaneously form oriented multilayer arrangements
[38]. The technique is very convenient for studying proteins
inserted into reconstituted vesicles (liposomes, virosomes)
can be used.
The possibility to gain information on the orientation of
different regions of the phospholipid molecules and on the
different protein secondary structures is certainly one of the
most exciting possibilities of ATR-FTIR spectroscopy. A
proper interpretation of the results supposes a minimum
understanding of the principles of the method.
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The method is based on the fact that the IR light
absorption is maximal if the dipole transition moment is
parallel to the electric field component of the incident light.
Aa
Bl¯
BQ
E¯


2
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BQ


2
E¯
 2cos2C ð1Þ
where C is the angle between ((Bl¯)/(BQ)) and E¯.
In an ordered membrane deposited on the germanium
crystal, all the molecules, and therefore the transition dipole
moments within the membrane molecules, have the same
orientation with respect to a normal to the IRE surface. By
measuring the spectral intensity while turning the incident
light electric field orientation with a polariser, it is possible
to gain information on the orientation of the dipoles. In fact,
all the orientational information is contained in the dichroic
ratio RATR, which is the ratio of the integrated absorbance of
a band measured with a parallel polarisation of the incident
light AO to the absorbance measured with a perpendicular
polarisation of the incident light A?:
RATR ¼ AO
A?
ð2Þ
RATR can be computed by averaging for all orientations
around the germanium crystal as well as for all orientations
with respect to this normal. The former averaging is trivial
since we suppose here a uniaxial symmetry for the distri-
bution around this normal (for details of the derivation, see
Ref. [39]). The latter averaging must take into account the
distribution of the orientations with respect to the normal
described by density distribution function. The dichroic
ratio RATR is related to an orientational order parameter
RATR ¼ E
2
x
E2y
þ E
2
z
E2y
1þ 3S
1 S
 
ð3Þ
where Ex
2, Ey
2 and Ez
2 are the time-averaged square electric
field amplitudes of the evanescent wave in the film at the
plate/film interface already described in Ref. [37]. Interest-
ingly, the evanescent wave exhibits electric field compo-
nents in all directions. Therefore, at the opposite to the
transmission situation, no tilt of the oriented membrane is
necessary to gain full information on dipole orientation. S is
defined as the projection of the density distribution function
C(C) on the second Legendre polynomial. For uniaxial
symmetry, it is computed as
S ¼
Z p
0
3cos2C 1
2
CðCÞsinðCÞdC ð4Þ
where C refers to the considered distribution. It appears here
that if the angular distribution function is developed in
Legendre polynomials, only the second term of this devel-
opment governs the dichroism in ATR-FTIR. The reader is
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specific case of ATR. For clarity of the subsequent discus-
sion, we consider below that the orientation of ana-helix long
axis with respect to the plate surface normal must be deter-
mined. The measured order parameter S, denoted below
Sexperimental, obtained from R
ATR through Eq. (2), can be gen-
erally expressed as a set of uniaxial symmetric distributions:
Sexperimental ¼ SmembraneShelixSdipole ð5Þ
where Smembrane describes the distribution function of the
lipid membrane patches (smallest planar membrane unit)
with respect to the internal reflection element, Shelix describes
the orientation of the helices with respect to the membrane
plane, and Sdipole describes the dipole orientation of either
amide I or amide II with respect to the helix axis. Shelix can be
further split by describing it as the convolution of an order
function Shelix order by a delta function describing the mean
angle of the helix with respect to a membrane perpendicular
Shelix angle:
Shelix ¼ Shelix angleShelix order ð6Þ
Because the transition dipole has a unique distribution of the
angle a, it can generally be described by a delta function. Eq.
(4) becomes
Sdipole ¼ 3cos
2a 1
2
ð7Þ
Shelix angle can now be evaluated from Sexperimental. Assuming
Shelix order = 1, the tilt b of the helix axis with respect to the
membrane normal can be determined provided that Sdipole
and Smembrane are known. It is usually considered that
Smembrane = 1 and Sdipole is a characteristic of the secondary
structure:
b ¼ arccos 2:Shelix angle þ 1
3
ð8Þ
2.4. Orientation of fusion peptides
A peptide can adopt defined orientation with respect to the
lipid matrix. We illustrate here with a few examples how such
an orientation can be determined by ATR-IR spectroscopy.
For amphipathic peptides, it is the distribution of amino acids
on the helix surface that determines the position in the lipid
bilayer. This point has been illustrated with LAH4, a syn-
thetic amphipathic helical peptide that has been designed to
change its orientation in the membrane in a pH-dependent
manner and allows the evaluation of the hydrophobic, polar
and electrostatic contributions that determine the orientation
of membranes polypeptides. LAH4 is 20 amino acids long
and contains 4 histidines; the other amino acids (leucine,
alanine) contribute to its hydrophobic character. The histi-
dines exhibit pK values between 5.4 and 6.0 and the
electrostatic contributions during membrane insertion are
therefore strongly dependent on pH. LAH4 was inserted into
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ously that at low pH, the helix axis is oriented close to the
membrane plane. At high pH, the helix axis is parallel to the
lipid acyl chains [40,41]. This peptide orientation has been
characterised by multidimensional solution and proton-
decoupled 15N solid state NMR spectroscopy [42].
A new factor that has emerged from the ATR-IR studies
was that HIV/SIV peptides were obliquely oriented into the
lipid bilayer of the host cell [43–45]. This was originally
predicted by calculation of the directions of the hydrophobic
moments, assuming that the sequences adopted a helical
conformation. It has been hypothesised that such an orienta-
tion requires the existence of a gradient of hydrophobicity
and hydrophilicity along the helix axes. Similar oblique
insertion angles were found for the HA fusion peptide when
using the same experimental conditions [46]. Mutation stud-
ies to deliberately alter the oblique angle of insertion were
found to disrupt fusion efficiency in both intact virus [47,48]
and synthetic fusion peptide systems [44,45,49,50] utilising
HIV/SIV and Bovine Leukemia Virus. Small-angle neutron
scattering from oriented membranes have also suggested that
SIV viral fusion peptide containing substituted deuterium
atoms is inserted into the lipid bilayer with an oblique angle
[51]. Recent NMR and spin label quenching data suggest that
a kink in the fusion peptide modifies the mode of insertion of
the peptide in the bilayer [52,53]. Similar insertion modes
have not been identified for other types of small membrane-
associating peptides and may be specific to the fusogenic
peptides. Support for the importance of the orientation also
comes from studies in which the N-terminal of the fusion
peptides is labelled with the NBD fluorophore, the emission
properties of, which are sensitive to the polarity of the
environment. For the Sendai fusion peptide, the N-terminal
of the more fusogenic G12Amutant was found to be closer to
the surface of the membrane than the wild-type, thus indicat-
ing a more oblique (closer to parallel) angle of insertion [54].
Fluorescently labelled peptide analogues can be used to
determine the peptide–membrane partition coefficient and
the position of the N terminus or C terminus in the membrane.
Using this technique for the fusion protein of Sendai virus
[54], show that a 33-residue peptide corresponding to the
NH2 terminus of the wild-type fusion protein is locatedwithin
the lipid bilayer and that the peptide tends to self-associate in
the membrane-bound state, while an ‘‘nonfusogenic’’ mutant
peptide lies on the surface of the bilayer but has the same
tendency to self-associate. The observed differences in the
peptide fusogenic activities are hypothesised to result from
the difference in the degree of penetration of the peptide into
the membrane [54]. Similar results were found for the HIV
fusion peptide, in which the N-terminal of the inactive V2E
mutant was inserted deeper than the wild type [50]. In
addition, both the membrane-bound Sendai and HIV fusion
peptides were found to be efficiently cleaved by proteinase K,
thus indicating only a shallow penetration into the bilayer.
This is in contrast to transmembrane-bound peptides, which
are typically protected from enzymatic cleavage [55]. Addi-tional studies indicate that the oblique angle of the inserted
helix causes a significant disruption of the alignment of the
phospholipid alkyl chains, which does not occur for the
parallel or perpendicular orientations [56,57]. It is postulated
that this gives rise to the lipid phases that are associated with
the initial events of membrane fusion. Since the oblique ori-
entation prevents the helix from fully transversing the bilayer,
it has also been suggested that this causes an expansion of the
membrane core, which in turn increases negative curvature
strain, destabilises the bilayer relative to the formation of
inverted phases and facilitates membrane fusion [49]. The
negative curvature strain would probably facilitate contact
between the viral and target cell membranes, which would
also probably increase the number of fusion proteins inserted
simultaneously into both membranes. In addition, the resul-
tant invagination will produce a region of high curvature at
which membrane fusion is likely to commence [58].
Fertilin is a guinea pig sperm surface membrane protein
that seems to play a role in sperm–eggmembrane fusion. The
two subunits a and h of fertilin share membrane topologies
and other characteristics with viral binding and fusion pro-
teins [59,60]. The h subunit contains a potential receptor
binding domain and the a subunit contains a putative fusion
peptide [9,10,61], suggesting that fusion events which occur
during fertilisation may share a common mechanism with
penetration of enveloped viruses into host cells. The sequence
recently suggested to be involved in fusion comprises resi-
dues 89–111 of the a-subunit of fertilin [9]. This sequence
fulfils all three criteria of an internal fusion peptide: (a) lo-
cated in a membrane anchored subunit, (b) relatively hydro-
phobic and (c) able to be modelled as a ‘‘sided’’ a-helix with
most of the bulky hydrophobic residues on one face and
charged amino acids on the other face [10]. This peptide has
been shown to cause membrane lysis and fusion [62].
The ATR-FTIR study [63] supports a model where the
peptide, upon binding to the lipid phase, adopts an almost
helical conformation with unordered structures only at the
ends of the helix. The contribution of the h-structure was
weak, suggesting that the h-sheet is not the main structure of
the membrane-bound fertilin peptide. There appears to be a
strong correlation between the oblique insertion of fertilin
fusion peptide into the membrane, its fusogenic properties
and its a-helical structure as shown for the viral fusion
peptide [63].
In summary, the position and orientation of the viral
fusion peptide within the fusion site is at least as important
as its hydrophobicity and secondary structure.3. Amide hydrogen/deuterium (H/D) exchange kinetics
Hydrogen isotope exchange has long been used for the
analysis of protein structure and dynamics [64–66] (for a
review, see Refs. [67,68]). It appeared to be one of the main
techniques able to identify submolecular motional domains
including fast exchanging protons of the protein surface,
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regions buried in the protein or involved in some secondary
structures and the slowly exchanging protons from the pro-
tein core formed by the most rigid clusters (knots) of amino
acids (for a review, see Ref. [69]). It has been suggested by
Lumry [69] that the description of proteins in terms of three
types of regions characterised by their particular dynamic
structure is functionally and evolutionarily more relevant
than a description in terms of secondary structures. The
slowly exchanging cluster has been related for several pro-
teins to the initial folding core during the sequence of events
leading to protein folding [70]. One particularity of IR
spectroscopy is that it allows one to monitor the exchange
rate of the amide protons only, yielding data that are directly
proportional to the number of amino acid residues in the
protein. Recent developments indicate that a careful analysis
of amide I in the course of deuteration makes it possible to
assign the exchanging protons to a secondary structure type
[71,72]. The high quality of the spectra obtained by the ATR-
FTIR method should allow further developments of its use in
this domain. The main advantage of this technique is that it
provides information about tertiary structural modifications
resulting from an environmental change (pH, ligand) even
though the secondary structure is not altered.
3.1. Experimental procedure and data recording
Since the recording of H/D exchange kinetics by ATR-
FTIR has only begun [73–80] but is not yet a standard
procedure, we briefly describe here the experimental proce-
dure. Thin films are obtained by slowly evaporating a sample
containing typically 100 Ag of protein or membrane suspen-
sion on one side of the ATR plate under a stream of nitrogen.
However, much smaller amounts can be used. Successful H/
D exchange analyses of reconstituted proteins, like P-glyco-
protein [80] or LmrA [73], were performed on 20 Ag of
protein per experiment. The germanium crystal is then placed
in an ATR holder for liquid sample with an inlet and outlet. H/
D exchange is obtained by flushing the sealed chamber in
contact with the sample with nitrogen gas saturated with D2O
by bubbling through a series of four vials containing D2O at a
flow rate of 50 ml min 1, controlled by a flow meter. Amide
H/D exchange was measured by monitoring the decrease in
the amide II absorption (1544 cm 1) as a function of the time
of exposure to D2O-saturated N2. Under the conditions
described above, the availability of D2O is not rate limiting
for the exchange. Moreover, varying the amount of material
(from 10 to 150 Ag) spread on the germanium crystal has no
influence on the kinetics measured, indicating that the
thickness of the film does not influence the D2O diffusion
in the film.
3.2. Amide H/D exchange in fusion peptides
The kinetics of deuteration of the fertilin fusion peptide
associated to LUV PC/PS (80:20%) and LUV PC/PS(60:40%) were measured [63], at constant pH (7.2) and
temperature (20 jC). The rate of amide H/D exchange is
related to the stability of the secondary structure and to the
solvent accessibility of the NH amide group of the protein
or peptide. Amide hydrogen exchange was measured by
monitoring the decrease in the amide II absorption (maxi-
mum at 1544 cm 1) as a function of the time of exposure to
D2O-saturated N2 (from 15 s to 2 h). The percentage of
deuteration of fertilin peptide associated to LUV of PC/PS
(80:20%) and PC/PS (60:40%) was calculated from the
amide II/amide I ratio. H/D exchange was faster and almost
complete for the peptide associated to the LUV containing
20% negatively charged lipids. After 20-min deuteration,
90% of the peptide N–H groups were exchanged, suggest-
ing a complete accessibility of the peptide to the solvent,
while when the fertilin peptide was associated to vesicles
containing 40% PS, only 20% of the peptide NH groups
were exchanged, suggesting less accessibility of the peptide
to the solvent [63]. This result fully confirms the FTIR
orientation, i.e., for vesicles containing 20% PS, the helix is
parallel to the lipid membrane and accessible to the solvent,
while for vesicle containing 40% PS, the helix is inserted
obliquely in the lipid bilayer and much less accessible to the
solvent.
A simplified membrane system, consisting of a fusion
peptide anchored to donor vesicles and a population of
target vesicles [81], demonstrated that fusion can be
regulated by a switch of the secondary structure of the
peptide from a nonfusogenic h-sheet to a fusion-permis-
sive a-helix, and vice versa. The positioning of the switch
is governed by the presence of distinct lipids in the target
membrane [81]. The accessibility to the peptide to deute-
rium oxide was lower in the presence than in the absence
of target membranes confirming that in these conditions
the peptide was shielded from the aqueous environment.
Surprisingly, at condition at which fusion is inhibited, i.e.,
in the presence of lysophosphatidylcholine (LPC), a further
decrease in the accessibility of the peptide to D2O was
observed. Prior to fusion, the peptide was fully accessible
to H/D exchange, which was completed after approximate-
ly 10–15 min. After fusion with target vesicles in the
absence of LPC, this exchange amounted to approximately
50–60%. The exchange was severely diminished when the
target contained LPC [81]. The degree of exchange is such
(approximately 20% compared with approximately 50% at
control condition) that it is unlikely that the exchange data
can be explained by an enhanced insertion of the peptide
at nonfusogenic conditions. Rather, a reasonable explana-
tion could be that the peptide becomes clustered at the
lipid/water interface in the h-sheet structure.4. Perspectives
It is obvious that studies with isolated peptides and
liposomes should be interpreted with care. A major point
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different from the one they adopt in the intact molecule.
A new approach has been recently developed in our group
[82,83] in order to provide information about membrane
domains dynamics. Monitoring the IR linear dichroism
spectra in the course of H/D exchange allowed to focus the
recording of exchange rates on the membrane-embedded
regions of the protein only. The dichroism present in the
intact protein can be completely explained by the dichroism
of the helices, which remain associated with the membrane
after proteinase K treatment [82,83]. This observation strong-
ly suggests that only the transmembrane helices contribute
significantly to the dichroism. Therefore this makes possible
to monitor structural changes occurring in the membrane
domains while working with the intact proteins. The analysis
of the structure and orientation of the fusion peptide in viral
proteins could be the benefit of this new approach.
In most cases, viral envelope proteins must first be
activated by a specific environmental stimulus before fusion
can start [84]. Such processing results in the exposure of the
fusion peptide at this N-terminal position. For the well-
studied hemagglutinin protein (HA) from influenza virus,
activation occurs by the exposure to an acidic environment in
the endosome vesicle (ca. pH 5.0–6.0), whereas for gp120/
41 (env) of HIV, activation occurs by binding with receptor
molecules in the target cell membrane (i.e., CD4 and CXCR4
or CCR5) [85–89]. In most of these systems, the structural
changes induced by a change in the environmental condi-
tions are limited to a small fraction of amino acids. The high
sensitivity of the H/D exchange measurements allows to
detect structural changes limited to a few amino acids and
would be an elegant way to characterise in viral proteins
structural changes due to environmental modifications.
The fusion peptides are much less fusogenic than the
corresponding intact fusion protein. The factors explaining
this discrepancy have been discussed extensively (multimers
formation, role of other domains of the protein). Clearly, the
mechanism by which viral proteins facilitate the formation
of fusion intermediates is a complex process involving
several domains of the fusion protein. Combining fluores-
cence quenching experiments and ATR-IR spectroscopy is a
possible approach to learn more about these intermediate
structural states and to study how such structural changes
are propagating along the protein structure [83].
IR dichroic spectra reflect conformational changes occur-
ring in the transmembrane, whereas fluorescence quenching
of tryptophan residues by soluble attenuators reveals struc-
tural changes located in the cytosolic domains. This new
approach has allowed to characterise structural states impli-
cated in drug transport mediated by resistance proteins
[82,83].
The fact that new IR developments allows to focus
specifically on structural changes occurring in the mem-
brane or in the soluble domain of a membrane protein and
that more purified viral proteins are available makes this
experimental strategy realistic and promising.Acknowledgements
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